These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8215016)

  • 1. Somatotroph insulin-like growth factor-I signaling.
    Prager D; Melmed S
    Ann N Y Acad Sci; 1993 Aug; 692():102-12. PubMed ID: 8215016
    [No Abstract]   [Full Text] [Related]  

  • 2. Human insulin-like growth factor I receptor 950tyrosine is required for somatotroph growth factor signal transduction.
    Yamasaki H; Prager D; Gebremedhin S; Melmed S
    J Biol Chem; 1992 Oct; 267(29):20953-8. PubMed ID: 1400411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 activation of extracellular signal-related kinase-1 and -2 in growth hormone-secreting cells.
    Webster J; Prager D; Melmed S
    Mol Endocrinol; 1994 May; 8(5):539-44. PubMed ID: 8058064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
    Miura M; Li S; Baserga R
    Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling.
    Hsu D; Knudson PE; Zapf A; Rolband GC; Olefsky JM
    Endocrinology; 1994 Feb; 134(2):744-50. PubMed ID: 8299569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human insulin-like growth factor I receptor internalization. Role of the juxtamembrane domain.
    Prager D; Li HL; Yamasaki H; Melmed S
    J Biol Chem; 1994 Apr; 269(16):11934-7. PubMed ID: 8163493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two alternatively spliced forms of the human insulin-like growth factor I receptor have distinct biological activities and internalization kinetics.
    Condorelli G; Bueno R; Smith RJ
    J Biol Chem; 1994 Mar; 269(11):8510-6. PubMed ID: 7510688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function of the human insulin-like growth factor-I receptor: a discordance of somatotroph internalization and signaling.
    Yamasaki H; Prager D; Melmed S
    Mol Endocrinol; 1993 May; 7(5):681-5. PubMed ID: 8316251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors.
    Langlois WJ; Sasaoka T; Yip CC; Olefsky JM
    Endocrinology; 1995 May; 136(5):1978-86. PubMed ID: 7720646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat pituitary GC cell insulin-like growth factor-I receptor regulation.
    Yamamoto H; Prager D; Yamasaki H; Melmed S
    Endocrinology; 1993 Sep; 133(3):1420-5. PubMed ID: 7689956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I receptor signalling: lessons from the somatotroph.
    Melmed S; Yamashita S; Yamasaki H; Fagin J; Namba H; Yamamoto H; Weber M; Morita S; Webster J; Prager D
    Recent Prog Horm Res; 1996; 51():189-215; discussion 215-6. PubMed ID: 8701079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors.
    Takata Y; Kobayashi M
    Diabete Metab; 1994; 20(1):31-6. PubMed ID: 8056133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatotroph response to periodical IGF-I administration to male rats.
    Pellizas CG; Bonaterra M; De Paul AL; Aoki A; Coleoni AH; Torres AI
    Acta Histochem; 2000 Nov; 102(4):439-51. PubMed ID: 11145536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies in insulin-like growth factor signaling? No, not really.
    Conover CA
    Growth Horm IGF Res; 2016; 30-31():42-44. PubMed ID: 27792888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
    Jansson M; Uhlen M; Nilsson B
    Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like compounds related to the amphioxus insulin-like peptide.
    Chu YC; Hu SQ; Zong L; Burke GT; Gammeltoft S; Chan SJ; Steiner DF; Katsoyannis PG
    Biochemistry; 1994 Sep; 33(37):11278-85. PubMed ID: 7727378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 1 (IGF-1) regulates prolactin, growth hormone, and IGF-1 receptor expression in the pituitary gland of the gilthead sea bream Sparus aurata.
    Mohammed-Geba K; Martos-Sitcha JA; Galal-Khallaf A; Mancera JM; Martínez-Rodríguez G
    Fish Physiol Biochem; 2016 Feb; 42(1):365-77. PubMed ID: 26486515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I (IGF-I) attenuation of growth hormone is enhanced by overexpression of pituitary IGF-I receptors.
    Yamasaki H; Prager D; Gebremedhin S; Melmed S
    Mol Endocrinol; 1991 Jul; 5(7):890-6. PubMed ID: 1658632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.